Display search results for ** instead (33 products)

Showing 31-33 of 33

This Vital Signs issue discusses Luminex's acquisition of Nanosphere, Medicare's changing approach to paying doctors, Orig3N's partnership with the San Francisco 49ers for collection of blood samples for research, and FDA's halt of Juno Therapeuticss cell therapy trial which left three dead.

USD 450.00

USD 337.50 save 25 %

This Vital Signs issue discusses Sinocare's acquisition of PTS Diagnostics, biosimilar drug pricing, Americans' usage of prescription pain killers, and Takara Bio's acquistion of Wafergen Bio-systems.

USD 450.00

USD 337.50 save 25 %

At the Manufacturing Leadership Council’s special "Manufacturing 4.0 in Action" event in Nuremberg, Germany, last November, a member of the audience raised the very pertinent question of standards in the M4.0 era. What standards around system interoperability and software could manufacturers rely upon as they moved toward greater connectivity bo...

USD 250.00

USD 187.50 save 25 %

Showing 31-33 of 33